Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

4.220 -22.260 (-84.06%)
Streaming Delayed Price Updated: 10:01 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences Inc

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
33 34 Next >
Why Is ZIM Integrated Shipping (ZIM) Stock Down Today?
ZIM Integrated Shipping (ZIM) stock is falling on Wednesday following the release of its earnings report for the second quarter of 2022. 
Via InvestorPlace
Why Is Hyzon Motors (HYZN) Stock Down Today?
Hyzon Motors (HYZN) stock is falling Wednesday after the hydrogen fuel cell vehicle company said it won't be able to file earnings on time. 
Via InvestorPlace
Why Is Cassava Sciences (SAVA) Stock Up 20% Today?
SAVA stock is rising on hopes of a buyout, which could also mean optimism for its Alzheimer's test and proposed treatment. 
Via InvestorPlace
Why Cassava Sciences Stock Is Ripping Higher Today
Shares of biotech firm Cassava Sciences Inc (NASDAQ: SAVA) are trading higher Wednesday after new filings showed recent insider buying. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
Over $2 Million Bet On Cassava Sciences; 4 Stocks Insiders Are Buying
Although US stocks closed mixed on Tuesday, there were a few notable insider trades. 
Via Benzinga
Cassava Sciences: Q2 Earnings Insights
  Cassava Sciences (NASDAQ:SAVA) reported its Q2 earnings results on Wednesday, August 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Cassava (SAVA) Stock Falls 30% on Report of Criminal Probe
SAVA stock is tumbling 30% in pre-market trading on a report that the Justice Department had launched a criminal probe of the company. 
Via InvestorPlace
Agilent, Cassava Sciences And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Cassava Sciences, Inc. (NASDAQ: SAVA) rose 19% to $24.02 in pre-market trading after new filings showed recent insider buying. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We've got the news behind the biggest pre-market stock movers for Wednesday morning that traders need to know about this morning! 
Via InvestorPlace
Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket
Gainers Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
  
Via Benzinga
Why Cassava Sciences Stock Is Soaring After Hours
Cassava Sciences Inc (NASDAQ: SAVA) shares are trading higher in Tuesday's after-hours session after new filings showed recent insider buying.  
Via Benzinga
CASSAVA SCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Cassava Sciences, Inc. - SAVA
From Kahn Swick & Foti, LLC
Via Business Wire
What Is Going on With Cassava Sciences (SAVA) Stock Today?
Cassava Sciences is moving higher on the day, as we have a "risk-on" rally in names like SAVA stock. Can the momentum last? 
Via InvestorPlace
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Thursday, 7/28, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
10 Stocks to Sell Before They Die
As the U.S. continues to struggle with stagflation, it’s becoming more important than ever to avoid pitfalls. 
Via InvestorPlace
Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati... 
Via Benzinga
Dow Rises 150 Points As Fed Boosts Rates By 0.75 Percentage Points
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
Cassava Sciences Responds to Media Reports
From Cassava Sciences, Inc.
Via GlobeNewswire
Big Tech Powers Stocks Higher Ahead of Fed Decision
The major indexes are on the rise midday, ahead of the Fed's highly anticipated interest rate decision. 
Via Talk Markets
Sherwin-Williams, Kraft Heinz And Some Other Big Stocks Moving Lower On Wednesday
Via Benzinga
Nasdaq Jumps Over 300 Points; Boeing Posts Wider-Than-Expected Loss
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 300 points on Wednesday. 
Via Benzinga
GOOG Stock Pops as Alphabet Earnings Report Shows Strong Ad Revenue
Alphabet (GOOG,GOOGL) stock is on the rise Wednesday as investors react to the tech giant's earnings report for the second quarter of 2022. 
Via InvestorPlace
Spotify (SPOT) Stock Gains on Impressive User Growth
Spotify (SPOT) stock is on the rise Wednesday as investors react to a strong earnings report for the second quarter of 2022. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 83 companies set new 52-week lows. 
Via Benzinga
Why U.S. Stocks Are Trading Higher Ahead Of Fed Decision; Alphabet Earnings Miss Views
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 250 points on Wednesday. 
Via Benzinga
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital... 
Via Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.